Vaccine News and Research

Latest Vaccine News and Research

New hepatitis B vaccine outperforms standard boosters in health care workers

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids.

24 Mar 2025

How your diet and probiotics can improve vaccine effectiveness

Researchers uncover how probiotics and diet shape the gut microbiome to boost vaccine efficacy, offering new avenues for precision immunization.

23 Mar 2025

Bacteria use dormant phages to create immunity against viral invaders

Like people, bacteria get invaded by viruses. In bacteria, the viral invaders are called bacteriophages, derived from the Greek word for bacteria-eaters, or in shortened form, "phages."

22 Mar 2025

WHO urges immediate investment of resources to maintain tuberculosis care

On the occasion on World Tuberculosis (TB) Day, marked on 24 March, the World Health Organization (WHO) is calling for an urgent investment of resources to protect and maintain tuberculosis (TB) care and support services for people in need across regions and countries.

21 Mar 2025

Registration Now Open for World Vaccine Congress Washington 2025: Leading Experts from Government, WHO, CEPI, and more to Speak

Register for the World Vaccine Congress 2025, the premier event for vaccine experts and leaders, driving innovations in public health and pandemic preparedness.

From World Vaccine Congress Washington 21 Mar 2025

Dance emerges as a powerful tool for stress relief

A narrative review highlights dance's unique role in stress regulation, enhancing mental well-being through social interaction and creative expression.

21 Mar 2025

KFF Health News' 'What the Health?': Federal health work in flux

Two months into the new administration, federal workers and contractors remain off-balance as the Trump administration ramps up its efforts to cancel jobs and programs — even as federal judges declare many of those efforts illegal and/or unconstitutional.

20 Mar 2025

Study reveals how B cells safeguard high-affinity antibodies

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating in hopes of generating the most effective antibodies.

19 Mar 2025

Research findings solve the paradox of how the immune system balances speed and precision

Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies through mutation and expansion until they produce high-affinity B cells adapted to keep different pathogens in check.

19 Mar 2025

Coalition of experts reaffirms vaccines as essential for public health

In response to growing concerns over vaccine misinformation, declining public trust in science, and recent outbreaks of preventable diseases, a coalition of 34 scientific and medical organizations, led by the American Association of Immunologists (AAI) and the American College of Physicians (ACP), has issued a unified statement emphasizing the critical role of vaccinations in public health.

18 Mar 2025

Moffitt researchers discover new vaccine strategy for treating specific type of breast cancer

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer.

18 Mar 2025

Third International Health Regulations Emergency Committee meeting addresses mpox upsurge

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) regarding the upsurge of mpox 2024, held on Tuesday, 25 February 2025, from 12:00 to 17:00 CET.

18 Mar 2025

Clinical trial of vaccine candidate to prevent Lassa fever begins enrollment

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

17 Mar 2025

Scientists say NIH officials told them to scrub mRNA references on grants

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their grant applications, two researchers said, in a move that signaled the agency might abandon a promising field of medical research.

17 Mar 2025

U.S. consumers still unaware of raw milk risks despite bird flu findings

Although the Food and Drug Administration (FDA) located H5N1 bird flu virus in samples of raw, or unpasteurized, milk in tests in four states in April 2024, and bird flu has been detected in commercially sold raw milk, many Americans do not know that consuming raw milk and its products poses greater health risks than consuming pasteurized milk and its products, especially for children.

14 Mar 2025

Older adults may have stronger immunity to bird flu, Penn study finds

Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian influenza virus, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

13 Mar 2025

Gut microbiota impacts pneumococcal vaccine response in immunodeficient individuals

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause various diseases, such as pneumonia.

13 Mar 2025

In Trump’s team, supplement fans find kindred spirits in search of better health

President Donald Trump's health officials want you to take your vitamins.

13 Mar 2025

Study: Poor sleep quality may increase susceptibility to conspiracy beliefs

A new study from the University of Nottingham has revealed that poor sleep quality may increase susceptibility to conspiracy beliefs, with depression likely playing a key role in this relationship.

12 Mar 2025

Study reveals key insights for preventing cytomegalovirus spread to fetuses

A new Weill Cornell Medicine and Oregon Health & Science University co-authored study provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus, or CMV, across the placenta to babies before they are born.

12 Mar 2025